Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 1 Kenneth W. Goodman, PhD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):536-538. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412. Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 2 Eta S. Berner, EdD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):539-541. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412. State of the Art and Science May 2003 Reducing HIV Transmission from Mother to Infant Audiey Kao, MD, PhD An HIV-positive expectant mother can deliver an HIV-negative baby with proper planning and treatment. Virtual Mentor. 2003;5(5):183-185. doi: 10.1001/virtualmentor.2003.5.5.cprl2-0305. Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408. Medicine and Society Oct 2004 Television on the Cutting Edge: Cosmetic Surgery Goes Prime-Time Leigh Turner, PhD Reality television programs that focus on cosmetic surgery show misguided viewers that such procedures are the key to emotional health and well-being. Virtual Mentor. 2004;6(10):462-464. doi: 10.1001/virtualmentor.2004.6.10.msoc1-0410. Medicine and Society Dec 2004 Routine Prenatal HIV Testing as a Standard of Care Getahun Aynalem, MD, MPH, Peter Kerndt, MD, MPH, and Kellie Hawkins, MPH There are various clinical and ethical arguments against the concept of implied consent for prenatal HIV testing. Virtual Mentor. 2004;6(12):566-569. doi: 10.1001/virtualmentor.2004.6.12.msoc1-0412. In the Literature May 2003 HIV Policy: Does Most Effective Equal Best? Susanna Smith Public health policies must not only demonstrate a concern for the general public but also respect individual patient privacy and confidentiality. Virtual Mentor. 2003;5(5):174-177. doi: 10.1001/virtualmentor.2003.5.5.jdsc2-0305. In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Next page Next › Last page Last »
Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 1 Kenneth W. Goodman, PhD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):536-538. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412.
Case and Commentary Dec 2004 Confusion over Cholesterol Testing, Commentary 2 Eta S. Berner, EdD Physicians must stay up-to-date on changes in clinical treatment guidelines. Virtual Mentor. 2004;6(12):539-541. doi: 10.1001/virtualmentor.2004.6.12.ccas2-0412.
State of the Art and Science May 2003 Reducing HIV Transmission from Mother to Infant Audiey Kao, MD, PhD An HIV-positive expectant mother can deliver an HIV-negative baby with proper planning and treatment. Virtual Mentor. 2003;5(5):183-185. doi: 10.1001/virtualmentor.2003.5.5.cprl2-0305.
Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408.
Medicine and Society Oct 2004 Television on the Cutting Edge: Cosmetic Surgery Goes Prime-Time Leigh Turner, PhD Reality television programs that focus on cosmetic surgery show misguided viewers that such procedures are the key to emotional health and well-being. Virtual Mentor. 2004;6(10):462-464. doi: 10.1001/virtualmentor.2004.6.10.msoc1-0410.
Medicine and Society Dec 2004 Routine Prenatal HIV Testing as a Standard of Care Getahun Aynalem, MD, MPH, Peter Kerndt, MD, MPH, and Kellie Hawkins, MPH There are various clinical and ethical arguments against the concept of implied consent for prenatal HIV testing. Virtual Mentor. 2004;6(12):566-569. doi: 10.1001/virtualmentor.2004.6.12.msoc1-0412.
In the Literature May 2003 HIV Policy: Does Most Effective Equal Best? Susanna Smith Public health policies must not only demonstrate a concern for the general public but also respect individual patient privacy and confidentiality. Virtual Mentor. 2003;5(5):174-177. doi: 10.1001/virtualmentor.2003.5.5.jdsc2-0305.
In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.